Calibre is a London-based healthtech company founded in 2025, pioneering the category of Causal Health Navigation. Its proactive health membership combines diagnostics, clinical expertise, and causal AI to help people understand their health and exactly how to change it. The UK is Calibre’s initial launch market, with plans to expand internationally in the future. The company has applied to become a CQC-regulated provider in the UK
where all clinical care is currently delivered by its partner DocTap, a CQC-registered
provider.
Calibre
Calibre
- Health
- London, United Kingdom
- £2.4m
- getcalibre.com
- Update Information
More venture news
- 29 Jul 2026

MiraeMirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
EquityHealth - 28 Jul 2026

DITTODITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
SeedHealth - 24 Jul 2026

TidalSenseTidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
EquityHealth
